Raj Maheshwari
Gründer bei Charlestown Capital Advisors LLC
Profil
Mr. Raj Maheshwari is a Chief Operating Officer at Cambelle-Inland LLC and a Managing Director at Charlestown Capital Advisors LLC.
He founded the firm Charlestown on August 2005.
Under his tenure, Charlestown Capital has been an M&A advisor to Esmark, Inc., a $1.3 billion steel company that was sold to OAO Severstal of Russia in August 2008.
Prior to Charlestown, Mr. Maheshwari was a portfolio manager and managing director at Weiss Peck and Great Investments.
From 1999 to August 2005, Mr. Maheshwari was a Portfolio Manager and Managing Director at WPG and its successor parent company Robeco Investment Management.
At WPG, he built and managed a $500 million (approximately) Risk Arbitrage and Special Situations/Event Driven hedge fund.
In Addition, at WPG and its parent company, Robeco Investment Management, he was involved in many aspects of investment management, including asset allocation, identifying new investment strategies, and overall new investment strategy.
From 1996 to 1999, Mr. Maheshwari was a Vice President of Research at Robert Fleming, Inc., where he helped run a $250 million (approximately) equity portfolio.
Mr. Maheshwari holds a BS in Mathematics and Computer Sciences from the State University of New York at Albany and an MBA from New York University.
Aktive Positionen von Raj Maheshwari
| Unternehmen | Position | Beginn |
|---|---|---|
Charlestown Capital Advisors LLC
 Charlestown Capital Advisors LLC Investment ManagersFinance Charlestown Capital Advisors LLC is a private equity firm located in the Financial District of New York City. The American company provides merchant banking, financial advisory, and M & A investment services. It was founded in 2005 by Raj Maheshwari. | Gründer | 01.08.2005 |
| Cambelle-Inland LLC | Geschäftsführer | 01.09.2013 |
Ehemalige bekannte Positionen von Raj Maheshwari
| Unternehmen | Position | Ende |
|---|---|---|
| ELAH HOLDINGS, INC. | Direktor/Vorstandsmitglied | 08.10.2017 |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | 19.10.2009 |
Robeco Weiss, Peck & Greer Investments
 Robeco Weiss, Peck & Greer Investments Investment ManagersFinance A subsidiary of Robeco Investment Management, Robeco Weiss, Peck & Greer Investments is an investment adviser headquartered in New York City with an additional office in Menlo Park, California. The firm was founded in 1970. Their ultimate parent is Cooperative Centrale Raiffeisen Boerenleenbank. | Portfolio Manager-Aktien | 31.01.2005 |
| Robert Fleming, Inc. | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Raj Maheshwari
| New York University | Masters Business Admin |
| State University of New York at Albany | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELAH HOLDINGS, INC. | Finance |
| Private Unternehmen | 5 |
|---|---|
Robeco Weiss, Peck & Greer Investments
Robeco Weiss, Peck & Greer Investments Investment ManagersFinance A subsidiary of Robeco Investment Management, Robeco Weiss, Peck & Greer Investments is an investment adviser headquartered in New York City with an additional office in Menlo Park, California. The firm was founded in 1970. Their ultimate parent is Cooperative Centrale Raiffeisen Boerenleenbank. | Finance |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
Charlestown Capital Advisors LLC
Charlestown Capital Advisors LLC Investment ManagersFinance Charlestown Capital Advisors LLC is a private equity firm located in the Financial District of New York City. The American company provides merchant banking, financial advisory, and M & A investment services. It was founded in 2005 by Raj Maheshwari. | Finance |
| Cambelle-Inland LLC | |
| Robert Fleming, Inc. | Finance |
